276 related articles for article (PubMed ID: 10193411)
21. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure.
Ferrari R; Bachetti T; Confortini R; Opasich C; Febo O; Corti A; Cassani G; Visioli O
Circulation; 1995 Sep; 92(6):1479-86. PubMed ID: 7664430
[TBL] [Abstract][Full Text] [Related]
22. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
23. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
24. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
25. Elevation of plasma-soluble tumour necrosis factor receptors (TNF-R) in sarcoidosis.
Nakayama T; Hashimoto S; Amemiya E; Horie T
Clin Exp Immunol; 1996 May; 104(2):318-24. PubMed ID: 8625527
[TBL] [Abstract][Full Text] [Related]
26. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
[TBL] [Abstract][Full Text] [Related]
27. Soluble tumor necrosis factor receptors in sera from patients with insulin-dependent diabetes mellitus: relations to duration and complications of disease.
Kulseng B; Vatten L; Espevik T
Acta Diabetol; 1999 Jun; 36(1-2):99-105. PubMed ID: 10436260
[TBL] [Abstract][Full Text] [Related]
28. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity.
Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Janowska J; Zurakowski A
Metabolism; 2004 Oct; 53(10):1268-73. PubMed ID: 15375781
[TBL] [Abstract][Full Text] [Related]
29. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
30. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
[TBL] [Abstract][Full Text] [Related]
31. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients.
Spoettl T; Hausmann M; Klebl F; Dirmeier A; Klump B; Hoffmann J; Herfarth H; Timmer A; Rogler G
Inflamm Bowel Dis; 2007 Jun; 13(6):727-32. PubMed ID: 17260368
[TBL] [Abstract][Full Text] [Related]
32. Increased serum soluble tumor necrosis factor receptor levels are associated with insulin resistance in liver cirrhosis.
Lin SY; Wang YY; Sheu WH
Metabolism; 2004 Jul; 53(7):922-6. PubMed ID: 15254888
[TBL] [Abstract][Full Text] [Related]
33. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of soluble tumour necrosis factor receptor-I (P55) and decreased IgG1 reactivities in HIV-1 patients with cytomegalovirus disease.
Jakobsen PH; Dodt KK; Meyer CN; Katzenstein T; Gerstoft J; Skinhøj P
Scand J Immunol; 1998 Jun; 47(6):591-5. PubMed ID: 9652828
[TBL] [Abstract][Full Text] [Related]
35. Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patients.
Zhang B; Huang YH; Chen Y; Yang Y; Hao ZL; Xie SL
Burns; 1998 Nov; 24(7):599-603. PubMed ID: 9882056
[TBL] [Abstract][Full Text] [Related]
36. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
[TBL] [Abstract][Full Text] [Related]
37. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis.
Jónasdóttir O; Petersen J; Bendtzen K
APMIS; 2001 Nov; 109(11):781-6. PubMed ID: 11900058
[TBL] [Abstract][Full Text] [Related]
38. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Saniabadi A
Am J Gastroenterol; 2004 Aug; 99(8):1532-8. PubMed ID: 15307873
[TBL] [Abstract][Full Text] [Related]
39. Soluble tumor necrosis factor alpha receptors in sera from leprosy patients.
Munk ME; Anding P; Schettini AP; Cunha MG; Kaufmann SH
Infect Immun; 1999 Jan; 67(1):423-5. PubMed ID: 9864247
[TBL] [Abstract][Full Text] [Related]
40. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
Girardin E; Roux-Lombard P; Grau GE; Suter P; Gallati H; Dayer JM
Immunology; 1992 May; 76(1):20-3. PubMed ID: 1321092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
